GlassScriptPhysician profile
Benjamin James Westbrook
NPI 1013170299
$16,935.72
in general payments reported to CMS, 2019-2025
25 companies · $1,243 in 2025
The $1,243 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $2,453 · 2021: $7,941 · 2022: $2,154 · 2023: $1,043 · 2024: $1,699 · 2025: $1,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,985.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,123.19 | 2019-2022 | |
| Intersect Ent, INC. | $2,760.26 | 2019-2022 | |
| Inspire Medical Systems, INC. | $2,646.17 | 2021-2025 | Inspire |
| Stryker Corporation | $2,500.98 | 2019-2025 | Scopis Ent, Xpress Ent Dilation System, Clarifix Cryotherapy Device |
| Medical Device Business Services, INC. | $1,112.03 | 2020-2021 | |
| Aerin Medical INC. | $777.82 | 2020-2025 | |
| Medtronic, INC. | $503.84 | 2022-2025 | Propel, Stealthstation S8 Platform, Fusion |
| Vertex Pharmaceuticals Incorporated | $331.51 | 2025 | |
| Merz North America, INC. | $289.06 | 2021-2022 | |
| Integra Lifesciences Corporation | $245.18 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Depuy Synthes Sales INC. | $226.55 | 2023-2025 | N/A, Truespan Orthocord, Speedtrap |
| Acclarent, INC | $203.06 | 2020-2021 | |
| Bolton Medical INC | $151.80 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Cochlear Americas | $149.89 | 2021-2022 | |
| Abbott Laboratories | $148.41 | 2024-2025 | Eterna |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $143.07 | 2025 | |
| Smith+Nephew, INC. | $139.62 | 2019-2022 | |
| Tactile Systems Technology INC | $136.23 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Medtronic USA, INC. | $115.16 | 2019-2020 | |
| Karl Storz Endoscopy-America | $100.16 | 2020-2021 | |
| Carestream Dental, LLC | $44.85 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $30.95 | 2025 | Tezspire |
| Atos Medical INC | $23.20 | 2024 | Provox Life Home Hme |
| Optinose US, INC. | $18.83 | 2021 | |
| Glaxosmithkline, LLC. | $13.90 | 2023 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Westbrook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.